Abstract
SUMMARY Rofenaid, a mixture of sulfadimethoxine and ormetoprim, at concentrations of 0.04, 0.02, and 0.01% in the feed, was evaluated for control of experimentally induced fowl cholera in turkeys. A different isolate of Pasteurella multocida was used in each of 4 different experiments. Exposure to 3 of the isolates was by injecting P. multocida into the palatine air spaces of the head; with the fourth isolate the palatine cleft was swabbed. Considering together the four isolates of P. multocida used for exposure, Rofenaid significantly (P<0.05) increased livability at both the 0.02 and 0.04% levels, and at the 0.04% level decreased the incidence of torticollis and of skull lesions in survivors. Exposure by injecting isolates from chronic infections into the palatine air spaces was comparable to swabbing the palatine cleft with the isolate from an acute infection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.